Cervical Length Pre-induction as a Tool to Predict Vaginal Birth

NCT ID: NCT02916082

Last Updated: 2016-09-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-11-30

Study Completion Date

2016-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the value of measuring cervical length as a predictor of vaginal birth after induction of labor with prostaglandins in pregnancies with 41 weeks of gestation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervical Length Measurement Pregnancy, Prolonged

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prolonged pregnancy

Pregnancies with 41 weeks or more of gestation determined by a reliable last menstrual period or early fetal ultrasound.

Cervical length measurement

Intervention Type PROCEDURE

Vaginal ultrasound to measure cervical length previous to use of prostaglandins.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cervical length measurement

Vaginal ultrasound to measure cervical length previous to use of prostaglandins.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 41 weeks or more of gestational age
* Cervical length measured by a FMF certified physician

Exclusion Criteria

* Any condition that could interfere with a possible vaginal birth (previous cesarean section, hypertensive disorders of pregnancies).
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Saint Thomas Hospital, Panama

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Osvaldo A. Reyes T.

Coordinator of Research

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Saint Thomas H

Panama City, Provincia de Panamá, Panama

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Panama

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2015-288V2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PREGNANT Short Cervix Trial
NCT00615550 COMPLETED PHASE3